MYLAN-NIFEDIPINE EXTENDED RELEASE
MYLAN PHARMACEUTICALS ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of MYLAN-NIFEDIPINE EXTENDED RELEASE in Canada?
A shortage of MYLAN-NIFEDIPINE EXTENDED RELEASE 60MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 14, 2026), but it has not started yet.
Why is MYLAN-NIFEDIPINE EXTENDED RELEASE not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will MYLAN-NIFEDIPINE EXTENDED RELEASE be available again?
The manufacturer's estimated resolution date is November 24, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Closest Matches
NIFEDIPINE ER
Extended-ReleasePRO DOC LIMITEE
JAMP NIFEDIPINE ER
Extended-ReleaseJAMP PHARMA CORPORATION
M-NIFEDIPINE ER
Extended-ReleaseMANTRA PHARMA INC
AG-NIFEDIPINE ER
Extended-ReleaseANGITA PHARMA INC.
Other Products
NIFEDIPINE
AA PHARMA INC
ADALAT XL
BAYER INC
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2026-11-24
~37 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02321149
Strength
60MG
Dosage Form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Active Ingredient
NIFEDIPINE
Tier
Unrated
Last Updated
2026-10-14
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
MYLAN-NIFEDIPINE EXTENDED RELEASE has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from MYLAN PHARMACEUTICALS ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
500MG · DIN 02385473
333MG · DIN 02293269
40MG · DIN 02257963
10MG · DIN 02257955
DIN 02388138
DIN 02388146
50MG · DIN 02468549
2G · DIN 02407310
1G · DIN 02407302
25MG · DIN 02247243
100MG · DIN 02247244
12.5MG · DIN 02554631